Literature DB >> 19860543

MYH9 related disease: a novel missense Ala95Asp mutation of the MYH9 gene.

Daniela de Rocco1, Paula G Heller, Giorgia Girotto, Annalisa Pastore, Ana C Glembotsky, Rosana F Marta, Valeria Bozzi, Alessandro Pecci, Felisa C Molinas, Anna Savoia.   

Abstract

MYH9-related disease (MYH9-RD) is a rare autosomal dominant disorder caused by mutations in MYH9, the gene encoding the heavy chain of non-muscle myosin IIA. Patients present with congenital macrothrombocytopenia and inclusion bodies in neutrophils and might develop sensorineural deafness, presenile cataract, and/or progressive nephritis leading to end-stage renal failure. In a family with eight individuals suffering from macrothrombocytopenia and hearing impairment we identified a novel c.Ala95Asp mutation. Affecting the motor domain of the protein, the mutation is likely to be associated with a severe phenotype. Therefore, this family should be carefully monitored to follow-up the renal status even though the affected members do not seem to be at risk of early kidney disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19860543     DOI: 10.3109/09537100903349620

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  5 in total

1.  Renal manifestations of patients with MYH9-related disorders.

Authors:  Kyoung Hee Han; HyunKyung Lee; Hee Gyung Kang; Kyung Chul Moon; Joo Hoon Lee; Young Seo Park; Il Soo Ha; Hyo Seop Ahn; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2011-01-06       Impact factor: 3.714

Review 2.  The role of vertebrate nonmuscle Myosin II in development and human disease.

Authors:  Xuefei Ma; Robert S Adelstein
Journal:  Bioarchitecture       Date:  2014-08-06

3.  Genetic contribution and associated pathophysiology in end-stage renal disease.

Authors:  Suraksha Agrawal; Ss Agarwal; Sita Naik
Journal:  Appl Clin Genet       Date:  2010-08-05

4.  MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.

Authors:  Alessandro Pecci; Catherine Klersy; Paolo Gresele; Kieran J D Lee; Daniela De Rocco; Valeria Bozzi; Giovanna Russo; Paula G Heller; Giuseppe Loffredo; Matthias Ballmaier; Fabrizio Fabris; Eloise Beggiato; Walter H A Kahr; Nuria Pujol-Moix; Helen Platokouki; Christel Van Geet; Patrizia Noris; Preethi Yerram; Cedric Hermans; Bernhard Gerber; Marina Economou; Marco De Groot; Barbara Zieger; Erica De Candia; Vincenzo Fraticelli; Rogier Kersseboom; Giorgina B Piccoli; Stefanie Zimmermann; Tiziana Fierro; Ana C Glembotsky; Fabrizio Vianello; Carlo Zaninetti; Elena Nicchia; Christiane Güthner; Carlo Baronci; Marco Seri; Peter J Knight; Carlo L Balduini; Anna Savoia
Journal:  Hum Mutat       Date:  2013-12-12       Impact factor: 4.878

5.  MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.

Authors:  Daniela De Rocco; Barbara Zieger; Helen Platokouki; Paula G Heller; Annalisa Pastore; Roberta Bottega; Patrizia Noris; Serena Barozzi; Ana C Glembotsky; Helen Pergantou; Carlo L Balduini; Anna Savoia; Alessandro Pecci
Journal:  Eur J Med Genet       Date:  2012-10-30       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.